14-88472374-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_007039.4(PTPN21):c.2741C>T(p.Ser914Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,613,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007039.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTPN21 | NM_007039.4 | c.2741C>T | p.Ser914Leu | missense_variant | 15/19 | ENST00000556564.6 | NP_008970.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTPN21 | ENST00000556564.6 | c.2741C>T | p.Ser914Leu | missense_variant | 15/19 | 1 | NM_007039.4 | ENSP00000452414 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152092Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000994 AC: 25AN: 251404Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135872
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461218Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 726962
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74434
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.2741C>T (p.S914L) alteration is located in exon 15 (coding exon 14) of the PTPN21 gene. This alteration results from a C to T substitution at nucleotide position 2741, causing the serine (S) at amino acid position 914 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at